COMPASS Pathways plcCMPS stock score: 34/100

$8.65 · +6.53% · Scored Nov 19, 2026

Technical
40
Fundamental
33
News
52

The reading

COMPASS Pathways (CMPS) scores 34 out of 100, which reads bearish, higher than 9% of Healthcare stocks and 10% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 33, technicals 40.

Among the fundamentals, Price Target at 100 and Analyst Consensus at 82 score highest, while Free Cash Flow Yield at 0 weighs the most against it.

On the daily chart, trend-following indicators average 20 and contrarian oscillators 67 — a split worth reading before trusting the technical total.

News sentiment is neutral at 52; it is shown, not counted in the composite.

Since Aug 22, 2026 the composite has ranged from 33 to 52, and it is down 14 points over the period.

About COMPASS Pathways

COMPASS Pathways (CMPS) is a London-based biotechnology company developing a psilocybin-based treatment for treatment-resistant depression, a condition affecting patients who have not improved with standard antidepressants. Its candidate, COMP360, is a synthetic, purified form of psilocybin, the active compound in so-called magic mushrooms, given in a single session or a small number of sessions under the supervision of trained therapists in a clinical setting. Two late-stage trials showed that COMP360 reduced depression symptoms compared with a very low control dose, with effects seen quickly and lasting for months in many patients, and the company is seeking U.S. approval. COMPASS has no product revenue and funds development with cash raised from investors, and it is preparing for a potential launch through specialized treatment centers.

COMPASS competes with Johnson & Johnson’s Spravato and with other companies developing psychedelic treatments for depression, including GH Research, AtaiBeckley and MindMed. Its edge rests on being among the first with late-stage data for a psychedelic depression treatment, a large clinical database and patents covering its formulation. Investors who follow CMPS stock tend to watch the regulatory review of COMP360 and launch preparations. Treatment center capacity, reimbursement and the scheduling of psilocybin by federal drug authorities are closely followed. Safety findings, cash runway and the progress of competing psychedelic therapies are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward CMPS’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

33

Pulling it up

  • Price target score compares the current stock price to analyst consensus targets.

  • Analyst consensus score synthesizes Wall Street analyst opinions, rating trends, and consensus ratings into a single metric.

  • Debt-to-Equity ratio measures financial leverage by comparing total debt to shareholder equity.

Holding it back

  • Free cash flow yield is free cash flow divided by market value: the cash a business generates for each dollar of its price.

  • Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.

  • Return on Assets (ROA) shows how efficiently a company uses its assets to generate profit.

25 weighted scorers; 14 had no data today and are left out rather than counted as zero.

Technical · daily

26

Pulling it up

  • The price change over the last 52 weeks.

  • Money Flow Index (14-period) is a volume-weighted RSI that identifies overbought and oversold conditions.

  • S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

Holding it back

  • Performance versus SPY compares the stock's returns to the S&P 500 index.

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Simple Moving Average (100-period) provides a longer-term perspective on price trends.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
52

Technical score by timeframe

ChartScoreWeight
Hourly521
Daily263
Weekly382
Monthly552

Composite score, last 90 days

05010034Aug 22, 2026Nov 19, 2026Aug 22, 2026: 48Aug 23, 2026: 49Aug 24, 2026: 51Aug 25, 2026: 52Aug 26, 2026: 52Aug 27, 2026: 50Aug 28, 2026: 49Aug 29, 2026: 48Aug 30, 2026: 48Aug 31, 2026: 49Sep 1, 2026: 47Sep 2, 2026: 48Sep 3, 2026: 49Sep 4, 2026: 47Sep 5, 2026: 48Sep 6, 2026: 48Sep 7, 2026: 49Sep 8, 2026: 51Sep 9, 2026: 50Sep 10, 2026: 50Sep 11, 2026: 51Sep 12, 2026: 50Sep 13, 2026: 50Sep 14, 2026: 51Sep 15, 2026: 48Sep 16, 2026: 48Sep 17, 2026: 51Sep 18, 2026: 51Sep 19, 2026: 51Sep 20, 2026: 51Sep 21, 2026: 51Sep 22, 2026: 50Sep 23, 2026: 49Sep 24, 2026: 45Sep 25, 2026: 46Sep 26, 2026: 46Sep 27, 2026: 46Sep 28, 2026: 46Sep 29, 2026: 45Sep 30, 2026: 43Oct 1, 2026: 43Oct 2, 2026: 42Oct 3, 2026: 43Oct 4, 2026: 43Oct 5, 2026: 43Oct 6, 2026: 43Oct 7, 2026: 44Oct 8, 2026: 43Oct 9, 2026: 44Oct 10, 2026: 44Oct 11, 2026: 44Oct 12, 2026: 41Oct 13, 2026: 41Oct 14, 2026: 41Oct 15, 2026: 43Oct 16, 2026: 40Oct 17, 2026: 41Oct 18, 2026: 41Oct 19, 2026: 42Oct 20, 2026: 44Oct 21, 2026: 45Oct 22, 2026: 43Oct 23, 2026: 41Oct 24, 2026: 42Oct 25, 2026: 42Oct 26, 2026: 42Oct 27, 2026: 44Oct 28, 2026: 45Oct 29, 2026: 46Oct 30, 2026: 43Oct 31, 2026: 43Nov 1, 2026: 43Nov 2, 2026: 38Nov 3, 2026: 37Nov 4, 2026: 37Nov 5, 2026: 35Nov 6, 2026: 37Nov 7, 2026: 37Nov 8, 2026: 38Nov 10, 2026: 39Nov 11, 2026: 39Nov 12, 2026: 34Nov 13, 2026: 37Nov 14, 2026: 35Nov 15, 2026: 34Nov 16, 2026: 34Nov 17, 2026: 33Nov 18, 2026: 34Nov 19, 2026: 34
Show the daily numbers
DateComposite
Nov 19, 202634
Nov 18, 202634
Nov 17, 202633
Nov 16, 202634
Nov 15, 202634
Nov 14, 202635
Nov 13, 202637
Nov 12, 202634
Nov 11, 202639
Nov 10, 202639
Nov 8, 202638
Nov 7, 202637
Nov 6, 202637
Nov 5, 202635
Nov 4, 202637
Nov 3, 202637
Nov 2, 202638
Nov 1, 202643
Oct 31, 202643
Oct 30, 202643
Oct 29, 202646
Oct 28, 202645
Oct 27, 202644
Oct 26, 202642
Oct 25, 202642
Oct 24, 202642
Oct 23, 202641
Oct 22, 202643
Oct 21, 202645
Oct 20, 202644
Oct 19, 202642
Oct 18, 202641
Oct 17, 202641
Oct 16, 202640
Oct 15, 202643
Oct 14, 202641
Oct 13, 202641
Oct 12, 202641
Oct 11, 202644
Oct 10, 202644
Oct 9, 202644
Oct 8, 202643
Oct 7, 202644
Oct 6, 202643
Oct 5, 202643
Oct 4, 202643
Oct 3, 202643
Oct 2, 202642
Oct 1, 202643
Sep 30, 202643
Sep 29, 202645
Sep 28, 202646
Sep 27, 202646
Sep 26, 202646
Sep 25, 202646
Sep 24, 202645
Sep 23, 202649
Sep 22, 202650
Sep 21, 202651
Sep 20, 202651
Sep 19, 202651
Sep 18, 202651
Sep 17, 202651
Sep 16, 202648
Sep 15, 202648
Sep 14, 202651
Sep 13, 202650
Sep 12, 202650
Sep 11, 202651
Sep 10, 202650
Sep 9, 202650
Sep 8, 202651
Sep 7, 202649
Sep 6, 202648
Sep 5, 202648
Sep 4, 202647
Sep 3, 202649
Sep 2, 202648
Sep 1, 202647
Aug 31, 202649
Aug 30, 202648
Aug 29, 202648
Aug 28, 202649
Aug 27, 202650
Aug 26, 202652
Aug 25, 202652
Aug 24, 202651
Aug 23, 202649
Aug 22, 202648

Key facts

Market cap
$1.2B
Sector
Healthcare
Industry
Medical Care Facilities
Beta
2.41
Risk grade (1–10)
—
Next earnings
Nov 3, 2026

Questions

What is CMPS's stock rating today?

CMPS scores 34/100 (Bearish) as of Nov 19, 2026: technical 40, fundamental 33, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.

What does COMPASS Pathways do?

COMPASS Pathways (CMPS) is a London-based biotechnology company developing a psilocybin-based treatment for treatment-resistant depression, a condition affecting patients who have not improved with standard antidepressants. Its candidate, COMP360, is a synthetic, purified form of psilocybin, the active compound in so-called magic mushrooms, given in a single session or a small number of sessions under the supervision of trained therapists in a clinical setting.

Is CMPS stock a buy?

The score is not a buy or sell recommendation. A 34 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the CMPS score calculated?

87 weighted scorers feed it today: 25 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

CMPS stock score

HTML

<a href="https://stocksscores.com/stocks/cmps/"><img src="https://stocksscores.com/stocks/cmps/badge.svg" alt="CMPS stock score" height="20"></a>

Markdown

[![CMPS stock score](https://stocksscores.com/stocks/cmps/badge.svg)](https://stocksscores.com/stocks/cmps/)